ClinicalTrials.Veeva

Menu

Comparative Clinical Performance of 59% Hioxifilcon A Contact Lenses vs. Marketed Hydrogel Contact Lenses (DDHyd)

V

Vision Service Plan

Status

Completed

Conditions

Refractive Error - Myopia Bilateral

Treatments

Device: Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)

Study type

Interventional

Funder types

Industry

Identifiers

NCT04671108
VS-20-02

Details and patient eligibility

About

The study will compare the short-term clinical performance and wearer and practitioner acceptability of a new-to-market spherical daily disposable (DD) hydrogel soft contact lens to a currently marketed spherical DD hydrogel soft contact lens.

Full description

This randomized clinical trial will compare the short-term clinical performance, and wearer acceptability of a new-to-market hioxifilcon A spherical daily DD contact lenses against marketed DD lenses in a short cross-over clinical trial.

The primary outcome variable for this study is overall subjective comfort.

Enrollment

50 patients

Sex

All

Ages

18 to 42 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Currently wearing spherical DD contact lenses at least 5 days/week
  • Vision correctable to 20/30 acuity in each eye with spherical DD contact lenses
  • No ocular or systemic disease that contra-indicates soft contact lens wear

Exclusion criteria

  • Participating in another clinical trial
  • Vision not correctable to 20/30

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

50 participants in 2 patient groups

Test to Moist
Experimental group
Description:
1 week of Test DD contact lenses followed by cross over to 1 week of 1-DAY ACUVUE® Moist contact lenses.
Treatment:
Device: Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)
Moist to Test
Active Comparator group
Description:
1 week of 1-DAY ACUVUE® Moist contact lenses followed by cross over to 1 week of Test DD contact lenses.
Treatment:
Device: Hioxifilcon A standard hydrogel contact lens with Hyaluronic Acid (HA)

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems